What is the Rubicon Research Ltd share price today?

The share price of NSE:RUBICON-EQ on 07 Sep 2026 (as of 11:00:07 IST) is ₹1771.40.

What is the NSE:RUBICON-EQ 52 week high low price?

Over the past 52 weeks (as of 07 Sep 2026), the NSE:RUBICON-EQ 52 week high low range shows a high of ₹1899.00 and a low of ₹570.75.

What is the Rubicon Research Ltd market cap?

As on 07 Sep 2026, Rubicon Research Ltd market cap is ₹29352.90 Cr.

What is the shareholding pattern of Rubicon Research Ltd Stock?

The shareholding pattern of Rubicon Research Ltd, as of last reported-on 30 Jun 2026 is: Promoters: 59.76% Foreign Institutional Investors (FII): 7.52% Domestic Institutional Investors (DII): 2.20% Mutual Funds: 7.23% Retail & Others: 23.29% This demonstrates an outstanding distribution of ownership.

What are the PE and PB ratios of Rubicon Research Ltd?

The Price-to-Earnings (PE) ratio of Rubicon Research Ltd is 101.84, and the Price-to-Book (PB) ratio is 10.14, as on 07 Sep 2026.

Rubicon Research Share Price

1676.10+1.30 (+0.08%)

+166.81% past 1 Year

Prices are delayed by 1 hour. Login or Sign Up for live updates.Prices are delayed by 1 hour. Login or Sign Up for live updates.

1 Day

+0.08%

1 Week

-4.28%

1 Month

-1.91%

3 Month

+18.32%

6 Month

+118.28%

YTD

+146.21%

1 Year

5 Year

10 Year

Max

+170.34%

YTD

10Y

MAX

Prices are delayed by 1 hour. Login or Sign Up for live updates.Prices are delayed by 1 hour. Login or Sign Up for live updates.

Price Analysis

1 Day

1 Week

1 Month

3 Months

6 Months

1 Year

Low

1641.00

1632.20

1286.30

755.60

570.75

High

1693.20

1764.30

1899.00

About

Rubicon Research is an integrated pharmaceutical company with business encompassing the entire value chain in the research, development and production of pharmaceutical products. Further, the company has robust sales and Read more

Pharmaceuticals & Drugs

Smallcap

Stock Analysis (SWOT)

StrengthsWeaknessesOpportunitiesThreats

1. Premium insight available after login

2. Sign in to view full SWOT analysis

3. Unlock strengths, weaknesses, opportunities & threats

QVT

Quality

0/100-

Valuation

0/100-

Technical

0/100-

Peer Stocks

1 week

1 month

1 year

Name

SUNPHARMANSE

DIVISLABNSE

TORNTPHARMNSE

ZYDUSLIFENSE

CIPLANSE

LAURUSLABSNSE

MANKINDNSE

DRREDDYNSE

AUROPHARMANSE

LUPINNSE

RUBICONNSE

LTP

1W Low

1W High

Market cap (₹)

1849.9+12.6 (0.69%)

1832.20

1891.50

4,47,476Cr

9602+227 (2.42%)

9312.50

9740

2,54,764Cr

4928.5+88.5 (1.83%)

4848.50

5010

1,89,423Cr

1180.3+20.3 (1.75%)

1152.10

1190.60

1,16,658Cr

1399+4.5 (0.32%)

1364.50

1419

1,11,484Cr

2026.2+72.2 (3.69%)

1963.80

2055.30

1,09,943Cr

2500+199.3 (8.66%)

2303

2504.30

1,01,712Cr

1200.4+15.4 (1.30%)

1185

1222

1,01,005Cr

1716-18 (-1.04%)

1689.30

1740

99,253Cr

2100.7+17.7 (0.85%)

2080

2135

96,031Cr

1685-66.1 (-3.77%)

1632.20

1764.30

27,713Cr

Rubicon Research Share Price

1676.10+1.30 (+0.08%)

+166.81% past 1 Year

Financial overview

Compounded Sales Growth

10 years-

5 years41%

3 years65%

Last year37%

Compounded Profit Growth

10 years-

5 years52%

3 years-

Last year84%

Stock Price CAGR

10 years-

5 years-

3 years-

1 year-

Return on Equity

10 years11%

5 years12%

3 years29%

Last year28%

CAGR%

Sales

Profits

Returns

ROE

10Y	5Y	3Y	TTM
-	41%	65%	37%
-	52%	-	84%
-	-	-	-
11%	12%	29%	28%

Peer Comparison

Symbol

SUNPHARMA

DIVISLAB

TORNTPHARM

ZYDUSLIFE

CIPLA

LAURUSLABS

MANKIND

DRREDDY

AUROPHARMA

LUPIN

RUBICON

Price	M.Cap (₹)	PE Ratio	EPS (₹)	EV/EBITDA	Annual PAT
1,849.9	₹447476 Cr	37	12.07	62.82	₹11479 Cr
9,602	₹254764 Cr	87.1	34.04	128.41	₹2568 Cr
4,928.5	₹189423 Cr	86.85	16.72	97.06	₹2163 Cr
1,180.3	₹116658 Cr	25.85	9.42	62.53	₹5040 Cr
1,399	₹111484 Cr	33.08	9.77	57.87	₹3879 Cr
2,026.2	₹109943 Cr	100.55	6.8	29.25	₹889 Cr
2,500	₹101712 Cr	49.79	13.75	71.08	₹1913 Cr
1,200.4	₹101005 Cr	31.35	5.32	63.99	₹4196 Cr
1,716	₹99253 Cr	26.73	17.95	96.84	₹3505 Cr
2,100.7	₹96031 Cr	17.37	30.95	154.35	₹5333 Cr
1,685	₹27713 Cr	96.15	5.13	20.48	₹247 Cr

Profit & Loss

Consolidated

Standalone

Quarterly

Yearly

₹

Balance Sheet

Consolidated

Standalone

₹

Name

Equity And Liabilities

Share Capital

Share Warrants & Outstandings

Total Reserves

Reserve excluding Revaluation Reserve

Shareholder's Funds

Minority Interest

Secured Loans

Unsecured Loans

Deferred Tax Assets / Liabilities

Other Long Term Liabilities

Long Term Provisions

Total Non-Current Liabilities

Current Liabilities

Trade Payables

Other Current Liabilities

Short Term Borrowings

Short Term Provisions

Total Current Liabilities

Total Liabilities

Contingent Liabilities

Total Debt

Assets

Gross Block

Less Accumulated Depreciation

Net Block

Capital Work in Progress

Non Current Investments

Long Term Investment

Long Term Loans & Advances

Other Non Current Assets

Total Non-Current Assets

Current Assets Loans & Advances

Currents Investments

Inventories

Sundry Debtors

Cash and Bank

Other Current Assets

Short Term Loans and Advances

Total Current Assets

Net Current Assets (Including Current Investments)

Total Assets

Book Value

Adjusted Book Value

Mar 2026	Mar 2025	Mar 2024	Mar 2023	Mar 2022	Mar 2021	Mar 2020	Mar 2019	Mar 2018
—	—	—	—	—	—	—	—	—
₹17 Cr	₹15 Cr	₹15 Cr	₹5 Cr	₹5 Cr	₹5 Cr	₹5 Cr	₹5 Cr	₹5 Cr
₹31 Cr	₹26 Cr	₹24 Cr	₹15 Cr	₹12 Cr	₹12 Cr	₹8 Cr	₹0	₹0
₹1241 Cr	₹499 Cr	₹346 Cr	₹267 Cr	₹288 Cr	₹357 Cr	₹327 Cr	₹192 Cr	₹174 Cr
₹1241 Cr	₹499 Cr	₹346 Cr	₹267 Cr	₹288 Cr	₹357 Cr	₹327 Cr	₹192 Cr	₹174 Cr
₹1289 Cr	₹541 Cr	₹385 Cr	₹286 Cr	₹305 Cr	₹374 Cr	₹341 Cr	₹197 Cr	₹178 Cr
₹10,000	₹10,000	₹0	₹0	₹0	₹3,000	₹0	₹0	₹0
₹143 Cr	₹64 Cr	₹93 Cr	₹97 Cr	₹63 Cr	₹38 Cr	₹4 Cr	₹28 Cr	₹12 Cr
₹0	₹0	₹0	₹0	₹36 L	₹35 L	₹0	₹0	₹0
-₹13 Cr	-₹2 Cr	-₹93 L	₹1 Cr	₹4 Cr	₹8 Cr	-₹3 Cr	₹30 L	₹2 Cr
₹47 Cr	₹50 Cr	₹55 Cr	₹0	₹2 Cr	₹5 Cr	₹7 Cr	₹0	₹0
₹12 Cr	₹10 Cr	₹4 Cr	₹3 Cr	₹1 Cr	₹1 Cr	₹81 L	₹2 Cr	₹43 L
₹189 Cr	₹123 Cr	₹151 Cr	₹102 Cr	₹71 Cr	₹53 Cr	₹9 Cr	₹31 Cr	₹14 Cr
—	—	—	—	—	—	—	—	—
₹377 Cr	₹239 Cr	₹177 Cr	₹97 Cr	₹57 Cr	₹33 Cr	₹19 Cr	₹20 Cr	₹10 Cr
₹154 Cr	₹93 Cr	₹75 Cr	₹46 Cr	₹33 Cr	₹33 Cr	₹28 Cr	₹25 Cr	₹11 Cr
₹68 Cr	₹290 Cr	₹264 Cr	₹196 Cr	₹91 Cr	₹43 Cr	₹19 Cr	₹14 Cr	₹14 Cr
₹237 Cr	₹164 Cr	₹56 Cr	₹23 Cr	₹2 Cr	₹1 Cr	₹12 Cr	₹10 Cr	₹50 L
₹836 Cr	₹786 Cr	₹572 Cr	₹361 Cr	₹184 Cr	₹111 Cr	₹78 Cr	₹69 Cr	₹35 Cr
₹2314 Cr	₹1450 Cr	₹1109 Cr	₹750 Cr	₹560 Cr	₹538 Cr	₹427 Cr	₹296 Cr	₹227 Cr
₹19 Cr	₹12 Cr	₹10 Cr	₹9 Cr	₹2 Cr	₹30 Cr	₹46 Cr	₹48 L	₹0
₹259 Cr	₹393 Cr	₹396 Cr	₹318 Cr	₹170 Cr	₹93 Cr	₹30 Cr	₹50 Cr	₹30 Cr
—	—	—	—	—	—	—	—	—
₹788 Cr	₹540 Cr	₹492 Cr	₹359 Cr	₹317 Cr	₹278 Cr	₹218 Cr	₹111 Cr	₹82 Cr
₹256 Cr	₹213 Cr	₹185 Cr	₹160 Cr	₹124 Cr	₹90 Cr	₹61 Cr	₹43 Cr	₹38 Cr
₹532 Cr	₹327 Cr	₹307 Cr	₹199 Cr	₹193 Cr	₹188 Cr	₹157 Cr	₹69 Cr	₹44 Cr
₹40 Cr	₹7 Cr	₹10 Cr	₹25 Cr	₹3 Cr	₹6 Cr	₹98 L	₹44 Cr	₹9 Cr
₹27 Cr	₹5 L	₹5 L	₹5 L	₹5 L	₹5 L	₹5 L	₹5 L	₹5 L
₹27 Cr	₹5 L	₹5 L	₹5 L	₹5 L	₹5 L	₹5 L	₹5 L	₹5 L
₹25 Cr	₹41 Cr	₹16 Cr	₹13 Cr	₹28 Cr	₹6 Cr	₹3 Cr	₹5 Cr	₹4 Cr
₹8 Cr	₹12 Cr	₹13 Cr	₹11 Cr	₹7 Cr	₹2 Cr	₹49 L	₹50 L	₹10 L
₹632 Cr	₹386 Cr	₹345 Cr	₹248 Cr	₹231 Cr	₹202 Cr	₹162 Cr	₹131 Cr	₹73 Cr
—	—	—	—	—	—	—	—	—
₹0	₹0	₹0	₹0	₹0	₹14 Cr	₹19 Cr	₹12 Cr	₹76 Cr
₹729 Cr	₹522 Cr	₹300 Cr	₹167 Cr	₹90 Cr	₹62 Cr	₹38 Cr	₹19 Cr	₹14 Cr
₹509 Cr	₹324 Cr	₹301 Cr	₹225 Cr	₹140 Cr	₹136 Cr	₹140 Cr	₹84 Cr	₹37 Cr
₹346 Cr	₹116 Cr	₹58 Cr	₹59 Cr	₹53 Cr	₹84 Cr	₹36 Cr	₹11 Cr	₹3 Cr
₹52 Cr	₹64 Cr	₹49 Cr	₹19 Cr	₹29 Cr	₹27 Cr	₹11 Cr	₹10 Cr	₹9 Cr
₹46 Cr	₹38 Cr	₹54 Cr	₹31 Cr	₹18 Cr	₹13 Cr	₹21 Cr	₹29 Cr	₹15 Cr
₹1682 Cr	₹1063 Cr	₹763 Cr	₹502 Cr	₹328 Cr	₹336 Cr	₹265 Cr	₹165 Cr	₹154 Cr
₹846 Cr	₹277 Cr	₹191 Cr	₹140 Cr	₹145 Cr	₹225 Cr	₹187 Cr	₹97 Cr	₹120 Cr
₹2314 Cr	₹1450 Cr	₹1109 Cr	₹750 Cr	₹560 Cr	₹538 Cr	₹427 Cr	₹296 Cr	₹227 Cr
₹76	₹33	₹24	₹536	₹578	₹714	₹656	₹419	₹380
₹76	₹33	₹24	₹18	₹19	₹24	₹22	₹14	₹13

Cash Flow

Consolidated

Standalone

₹

Name

Profit Before Tax

Adjustment

Changes In working Capital

Cash Flow after changes in Working Capital

Cash Flow from Operating Activities

Cash Flow from Investing Activities

Cash Flow from Financing Activitie

Net Cash Inflow / Outflow

Opening Cash & Cash Equivalents

Effect of Foreign Exchange Fluctuations

Closing Cash & Cash Equivalent

Mar 2026	Mar 2025	Mar 2024	Mar 2023	Mar 2022	Mar 2021	Mar 2020	Mar 2019	Mar 2018
₹321 Cr	₹195 Cr	₹103 Cr	-₹11 Cr	-₹66 Cr	₹63 Cr	₹74 Cr	₹27 Cr	₹49 L
₹108 Cr	₹93 Cr	₹71 Cr	₹46 Cr	₹28 Cr	₹34 Cr	₹28 Cr	₹16 Cr	₹10 Cr
-₹115 Cr	-₹90 Cr	-₹135 Cr	-₹108 Cr	-₹16 Cr	-₹9 Cr	-₹70 Cr	-₹57 Cr	-₹26 Cr
₹314 Cr	₹198 Cr	₹39 Cr	-₹73 Cr	-₹54 Cr	₹88 Cr	₹32 Cr	-₹14 Cr	-₹16 Cr
₹205 Cr	₹159 Cr	₹21 Cr	-₹75 Cr	-₹63 Cr	₹57 Cr	₹5 Cr	-₹14 Cr	-₹16 Cr
-₹410 Cr	-₹65 Cr	-₹69 Cr	-₹34 Cr	-₹55 Cr	-₹36 Cr	-₹84 Cr	₹4 Cr	₹20 Cr
₹283 Cr	-₹40 Cr	₹44 Cr	₹123 Cr	₹63 Cr	₹52 Cr	₹80 Cr	₹16 Cr	-₹3 Cr
₹78 Cr	₹55 Cr	-₹4 Cr	₹14 Cr	-₹55 Cr	₹73 Cr	₹1 Cr	₹7 Cr	₹1 Cr
₹105 Cr	₹51 Cr	₹54 Cr	₹39 Cr	₹84 Cr	₹9 Cr	₹10 Cr	₹3 Cr	₹2 Cr
₹2 Cr	-₹19 L	₹13 L	₹2 Cr	₹9 Cr	₹3 Cr	₹0	₹0	₹0
₹186 Cr	₹105 Cr	₹51 Cr	₹54 Cr	₹39 Cr	₹84 Cr	₹11 Cr	₹10 Cr	₹3 Cr

Fundamental Ratios

Consolidated

Standalone

Rubicon Research Share Price

1676.10+1.30 (+0.08%)

+166.81% past 1 Year

Shareholding summary

Promoters

59.76%

FII

7.52%

DII

2.2%

7.23%

Others

23.29%

Promoters

FII

DII

Others

Quarterly

Yearly

Shareholding Pattern

Quarterly

Yearly

Name

Promoters

FII

DII - Others

DII - MFs

Retail & Others

Jun 2026	Mar 2026	Dec 2025	Oct 2025
59.76%	59.86%	59.99%	59.99%
7.52%	7.54%	7.99%	9.38%
2.20%	2.88%	2.83%	4.12%
7.23%	7.14%	6.61%	5.63%
23.29%	22.58%	22.58%	20.88%

Bulk & block deals

Name

Hdfc Mutual Fund

Icici Prudential Mutual Fund

Kotak Mahindra Mutual Fund

Sbi Mutual Fund

Nomura India Investment Fund Mother Fund

Axis Mutual Fund

Timf Holdings

Aranda Investments Pte. Ltd.

General Atlantic Singapore Rr Pte Ltd

Deal Date	Action	Deal Value	Deal Price	Qty Traded	Deal Type	%Stake Traded	Exchange
26 Aug 2026	Purchase	809.75 Cr	₹1,660	48.78 L	Bulk	2.946869	BSE
26 Aug 2026	Purchase	300 Cr	₹1,660	18.07 L	Bulk	1.091769	BSE
26 Aug 2026	Purchase	275 Cr	₹1,660	16.57 L	Bulk	1.000788	BSE
26 Aug 2026	Purchase	200 Cr	₹1,660	12.05 L	Bulk	0.727845	BSE
26 Aug 2026	Purchase	199.86 Cr	₹1,660	12.04 L	Bulk	0.727352	BSE
26 Aug 2026	Purchase	150 Cr	₹1,660	9.04 L	Bulk	0.545883	BSE
26 Aug 2026	Purchase	150 Cr	₹1,660	9.04 L	Bulk	0.545883	BSE
26 Aug 2026	Purchase	140 Cr	₹1,660	8.43 L	Bulk	0.509492	NSE
26 Aug 2026	Sell	2,159.61 Cr	₹1,660	1.30 Cr	Bulk	7.859332	BSE
26 Aug 2026	Sell	140 Cr	₹1,660	8.43 L	Bulk	0.509492	NSE

Insider trading & SAST

Client name

Girish Subramaniam Iyer

Vinayak Sawant

General Atlantic Singapore Rr Pte Ltd

Sanjay Renapurkar

Sarabjit Singh

Reported on	Client category	Action	%Stake traded	Holding % post deal	Deal value	Deal price	Qty traded	Deal period	Deal mode	Post transaction holding	Insider/SAST	Regulation type	Security type
15 Sep 2026	Employee	Disposal	0.001812	0.03	54.89 L	₹1,829.80	3 K	11 Sep 2026	Market Sale	48,220	Insider Trading	—	Equity
15 Sep 2026	Employee	Disposal	0.000906	0.03	27.32 L	₹1,821	1.50 K	09 Sep 2026	Market Sale	52,516	Insider Trading	—	Equity
15 Sep 2026	Employee	Disposal	0.000783	0.03	23.18 L	₹1,788.48	1.30 K	10 Sep 2026	Market Sale	51,220	Insider Trading	—	Equity
15 Sep 2026	Employee	Disposal	0.000604	0.03	18.10 L	₹1,809.90	1 K	08 Sep 2026	Market Sale	54,016	Insider Trading	—	Equity
04 Sep 2026	Employee	Disposal	0.000665	0	20.28 L	₹1,843.54	1.10 K	28 Aug 2026	Market Sale	7,307	Insider Trading	—	Equity
28 Aug 2026	Promoter	Disposal	8.368824	27.34	2,299.61 Cr	₹1,660	1.39 Cr	26 Aug 2026	Market Sale	4,52,58,360	Insider Trading	—	Equity
28 Aug 2026	Promoter	Disposal	0.088761	35.7	25.42 Cr	₹1,729.82	1.47 L	25 Aug 2026	Market Sale	5,91,11,433	Insider Trading	—	Equity
25 Aug 2026	Employee	Disposal	0.002416	0	70.10 L	₹1,752.50	4 K	19 Aug 2026	Market Sale	2,000	Insider Trading	—	Equity
25 Aug 2026	Employee	Disposal	0.001208	0	35.81 L	₹1,790.54	2 K	20 Aug 2026	Market Sale	0	Insider Trading	—	Equity
21 Aug 2026	Employee	Disposal	0.021144	0.15	1.75 K	₹0.05	35 K	18 Aug 2026	Market Sale	2,46,816	Insider Trading	—	Equity

Rubicon Research Share Price

Price Analysis

Share Price Live Stats

Share Market Cap & Key Ratios Overview

About

Stock Analysis (SWOT)

QVT

Peer Stocks

Rubicon Research Share Price

Rubicon Research Share Price

Financial overview

Compounded Sales Growth

Compounded Profit Growth

Stock Price CAGR

Return on Equity

Peer Comparison

Profit & Loss

Balance Sheet

Cash Flow

Fundamental Ratios

Rubicon Research Share Price

Rubicon Research Share Price

Oscillators

Moving averages

Rubicon Research Share Price

Shareholding summary

Shareholding Pattern

Bulk & block deals

Insider trading & SAST

Rubicon Research Share Price

Corporate Actions

Company details

Rubicon Research Share Price

Corporate filings & documents

Announcements

Annual reports

Concalls & investor presentations

Rubicon Research Share Price

News

Rubicon Research reports Profit after tax of 70.02 Crores, in the March 2026 quarter

Rubicon Research reports higher Q4 EBITDA and improved margin

Rubicon Research Q4 results show strong profit and revenue growth YoY

USFDA completes inspection at Rubicon Research’s R&D facility in Canada

Rubicon Research informs about disclosure

Rubicon Research gains on inking pact to acquire 85% stake in Arinna Lifesciences

Motilal Oswal Maintains Buy on Rubicon Research, Raises Target to Rs 955.

Rubicon Research Acquires 85% Stake in Arinna Lifesciences for Rs 200 Crores.

Rubicon Research to acquire 85% stake in Arinna Lifesciences

Rubicon Research - Quaterly Results

Rubicon Research Reports Strong Q3 EBITDA Growth to Rs 110 Crores, Margin at 22.75%.

Rubicon Research Q3 Consolidated Net Profit Rises 91% YoY to Rs 72.80 Crores, Revenue Up 52% to Rs 476 Crores.

Rubicon Research informs about outcome of board meeting

Rubicon Research reports Profit after tax of 37.18 Crores, in the December 2025 quarter

Rubicon Research rises on incorporating wholly owned subsidiary in Saudi Arabia

Rubicon Research guides for strong Q2FY26 growth, targets expansion and plant commissioning.

Rubicon Research posts strong YoY growth in Q2 FY26 EBITDA and margin improvement.

Rubicon Research reports Q2 FY2025 consolidated net profit and revenue growth on YoY basis.

Rubicon Research reports Profit after tax of 45.81 Crores, in the September 2025 quarter

Rubicon Research to acquire common stock in Neuronasal

Rubicon Research Ltd Share Price Today

Rubicon Research Quick Links

Other Stocks

Calculators

Brokerage Calculator

Stock Average Calculator

MTF Calculator

Margin Calculator

Span Margin Calculator